Find out about our ongoing research studies and how to get involved
Deep & Frequent Phenotyping Study (DFP)
The DFP study tracks biological and cognitive markers of Alzheimer's disease across time to find the best combination to detect disease change.
The PREVENT Dementia Research Programme investigates mid-life risk factors for Alzheimer's disease
EPAD Scotland is a continuation of the EPAD LCS designed to idenitfy the earliest markers of Alzheimer's Disease
Biogen EMBARK Study
The Biogen EMBARK Trial is a phase III clinical drug trial to evaluate safety and tolerability of aducanumab in participants with Alzheimer's disease who had previously participated in the earlier aducanumab studies.